Newsletter | March 11, 2026

03.11.26 -- RNA Delivery Technologies: Industrial Applications & Emerging Innovations

SPONSOR

Join Advancing RNA Chief Editor Anna Rose Welch on March 26 at 11 am ET for Advancements in gRNA Manufacturing & Quality. In this discussion with our knowledgeable panelists, we’ll dig into where the biggest gaps remain in our understanding of guide RNA quality and what improvements to the analytical toolbox/manufacturing paradigm need to be made to improve the overall understanding and quality of guide RNA. Register for free today.

FEATURED EDITORIAL

mRNA Hot Takes: Fighting Complacency And "Alternative Facts" In 2026

In episode 2 of mRNA Hot Takes, the show where we talk about serious RNA things, but with a spicy twist, Advancing RNA's ARW sits down with Sophia Lugo and  Michelle Lynn Hall to learn their wish lists for RNA developments for 2026 and their take on an edited quote by Oscar Wilde: “The mRNA industry can survive everything but…?”

Regulatory Considerations For Innovations In Oligonucleotide Supply Chains

Oligonucleotide therapeutics have rapidly advanced into late-stage and commercial development, shifting regulatory focus toward the maturity of manufacturing and supply chain control rather than therapeutic novelty. Regulatory success now depends on how effectively sponsors translate innovative chemistries into well-characterized, scalable, and sustainable materials and processes.

RNA Delivery Tech: Industrial Applications And Emerging Innovations

RNA delivery is moving from breakthrough to backbone. This review examines how LNPs and emerging carriers are reshaping scalability, targeting, manufacturing, and real-world deployment of RNA therapeutics.

INDUSTRY INSIGHTS

Developing Robust mRNA Processes In A cGMP Environment

Transitioning to commercial mRNA scales requires rigorous process validation. Explore emerging technologies and strategies to optimize manufacturing within a strictly regulated environment.

Levers To Optimize The IVT Reaction For Increased mRNA Yield

Mastering IVT yield requires balancing magnesium and nucleotide ratios. Learn how specific buffers and pyrophosphatase optimize mRNA synthesis for scalable, high-quality therapeutic production.

Refining mRNA Workflows Through Analytics And Component Identification

Optimize mRNA development by learning key strategies for process refinement, critical component identification, and in-process analytics to enhance therapeutic production.

Determining RNA Integrity And Purity By Capillary Gel Electrophoresis

Maintaining product quality requires precise integrity testing. Examine a study evaluating the performance of capillary gel electrophoresis in detecting impurities and verifying RNA stability.

Oligonucleotide Purification And Synthesis With Resin Screening

High-purity chromatography workflows depend on method optimization. Review a 21-mer oligo case study focused on resin selection and successful scale-up strategies for reliable purification.

The Hidden Secrets Of AEX Oligonucleotide Analysis

Fine-tuning pH and ionic strength is essential for identifying truncated sequences. Discover how to transform complex purification challenges into reproducible data for reliable oligo analysis.

SOLUTIONS

Biologics Manufacturing Partnership To Meet Your Needs

Process Chemicals For RNA Drug Manufacturing

Innovative RNA Manufacturing: Breaking Barriers With Mutant T7 Polymerase